Unlock AI-driven, actionable R&D insights for your next breakthrough.

L-Methionine Methionine Sulfoxide Formation: Mechanisms, Detection, And Biotechnological Implications

NOV 17, 202670 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
L-Methionine methionine sulfoxide formation represents a critical oxidative modification in protein biochemistry, where the sulfur atom in methionine residues undergoes oxidation to form methionine sulfoxide (MetO). This reversible post-translational modification plays pivotal roles in oxidative stress responses, protein function regulation, and cellular redox homeostasis 2. Understanding the formation mechanisms, detection methodologies, and enzymatic reversal pathways of methionine sulfoxide is essential for researchers developing oxidation-resistant biopharmaceuticals, optimizing L-methionine production processes, and investigating age-related protein damage 1,2,12.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Mechanisms Of L-Methionine Oxidation To Methionine Sulfoxide

The oxidation of L-methionine to methionine sulfoxide occurs through the reaction of the thioether sulfur atom with reactive oxygen species (ROS) or other oxidizing agents 2. This process generates two diastereomeric forms: methionine-S-sulfoxide and methionine-R-sulfoxide, due to the creation of a chiral center at the sulfur atom 2. The formation of methionine sulfoxide in proteins can significantly alter their structural and functional properties, as the introduction of a polar sulfoxide group disrupts hydrophobic interactions and may affect protein folding 2,12.

Key oxidative pathways include:

  • ROS-mediated oxidation: Hydrogen peroxide, hydroxyl radicals, and superoxide anions directly oxidize methionine residues in proteins under oxidative stress conditions 2
  • Chemical oxidant exposure: Industrial processes and analytical methods may employ oxidizing agents that convert methionine to methionine sulfoxide, as demonstrated in the preparation of oxidized zein proteins for antibody generation 2
  • Further oxidation potential: Under strong oxidizing conditions, methionine sulfoxide can be further oxidized to methionine sulfone, representing a more stable and irreversible modification 4

The susceptibility of methionine to oxidation makes it function as an endogenous antioxidant in proteins, protecting more critical residues from oxidative damage 2. Research on methionylmethionine stereoisomers has revealed that oxidation products (mono- and di-sulfoxides, as well as sulfones) exhibit altered physicochemical properties, including increased water solubility and reduced odor compared to the parent compound 4. Specifically, the oxidation of D-methionyl-L-methionine, L-methionyl-D-methionine, and D-methionyl-D-methionine stereoisomers produces sulfoxides and sulfones with controllable solubility profiles depending on the oxidation stage 4.

Detection And Quantification Methods For Methionine Sulfoxide

Antibody-Based Detection Approaches

Novel immunological methods have been developed for the specific detection of methionine sulfoxide residues in proteins 2. Antibodies recognizing methionine sulfoxide are generated by immunizing animals with modified proteins containing methionine sulfoxide residues, such as oxidized methionine-rich zein proteins 2. These antibodies enable:

  • Identification of proteins with elevated methionine sulfoxide levels in response to oxidative stress or neurodegenerative diseases 2
  • Screening for methionine sulfoxide-containing polypeptides in biological samples 2
  • Development of diagnostic tests for detecting oxidative protein damage in clinical specimens 2

The antibodies can be produced as monoclonal, polyclonal, or humanized forms in various animal systems, providing flexibility for different research and diagnostic applications 2.

Chemical Differentiation Methods

Traditional chemical approaches exploit the differential reactivity of methionine versus methionine sulfoxide 12. Cyanogen bromide selectively reacts with methionine residues to form methyl cyanide but does not react with methionine sulfoxide 12. However, this method presents significant practical challenges:

  • High toxicity and volatility of reagents (cyanogen bromide) and products (methyl cyanide) 12
  • Generation of oxidizing by-products that can artifactually convert methionine to methionine sulfoxide during analysis 12
  • Extended reaction times (several hours) required for completion 12

These limitations have driven the development of alternative enzymatic and fluorescence-based detection methods 12.

Enzymatic Assay Systems

Methionine sulfoxide reductase (MSR) enzymes provide the basis for sensitive enzymatic detection systems 12. The enzyme catalyzes the reduction of methionine sulfoxide back to methionine using reducing reagents such as thioredoxin or dithiothreitol (DTT) as electron donors 12. Novel fluorescently-labeled reducing agents bearing covalently-linked reporter tags enable quantification of methionine sulfoxide through measurement of oxidized reducing reagent formation, which is proportional to the methionine sulfoxide content in the sample 12. This approach offers advantages over radioactive methods previously employed, such as the radiolabeled acetyl methionine sulfoxide assay described by Brot et al. (1982) 12.

Enzymatic Reversal: Methionine Sulfoxide Reductase Systems

The biological reduction of methionine sulfoxide to methionine is catalyzed by methionine sulfoxide reductase enzymes, which play critical roles in cellular defense against oxidative stress 12. These enzymes utilize disulfide reducing reagents as substrates to provide reducing equivalents for the reaction 12. The MSR system demonstrates stereospecificity, with distinct enzyme forms (MsrA and MsrB) reducing the S- and R-diastereomers of methionine sulfoxide, respectively 2.

Key characteristics of MSR-catalyzed reactions include:

  • Substrate specificity: MSR enzymes can reduce both free methionine sulfoxide and methionine sulfoxide residues within peptides and proteins 12
  • Cofactor requirements: The reaction typically requires reducing agents such as thioredoxin, DTT, or NADPH-dependent electron transfer systems 12
  • Reversibility: The MSR system enables cells to repair oxidatively damaged proteins, restoring their function after oxidative stress episodes 2

The development of MSR-based assays has enabled researchers to quantify methionine sulfoxide in protein samples by measuring the consumption of reducing equivalents or the production of reduced methionine 12. These enzymatic methods offer superior sensitivity and specificity compared to chemical approaches, particularly for complex biological samples 12.

Implications For L-Methionine Production Processes

Oxidative Side Reactions In Biotechnological Synthesis

Industrial production of L-methionine through biotechnological routes must account for potential oxidative modifications during synthesis and purification 1,5,8,9. Modern processes employ enzymatic reactions between L-methionine precursors (such as O-acetyl-L-homoserine) and sulfur-containing reagents like methyl mercaptan or dimethyl disulfide (DMDS) 1,5,8,9. During these multi-step syntheses, exposure to oxidizing conditions or residual oxidants can lead to methionine sulfoxide formation, reducing product yield and quality 1,9.

Key process considerations include:

  • Precursor protection: O-acetyl-L-homoserine and intermediate compounds must be maintained under reducing conditions to prevent oxidation 8
  • DMDS handling: When dimethyl disulfide is used as a sulfur source, enzymatic hydrogenolysis to methyl mercaptan must be carefully controlled to avoid oxidative side reactions 1,5,9
  • Cofactor management: Enzymatic systems employing dehydrogenases and reductases with common cofactors (such as NAD+/NADH) require careful redox balance to prevent methionine oxidation 1,5,11

The two-step biotechnological process described in patents involves first generating methyl mercaptan from DMDS through enzymatic reduction using hydrogen, catalytic amounts of thiol-bearing amino acids or peptides, and enzymes catalyzing disulfide bridge reduction 1,5,11. This methyl mercaptan then reacts with L-methionine precursors to form L-methionine 1,8,9. Throughout this process, maintaining reducing conditions is critical to prevent methionine sulfoxide formation 1,5.

Quality Control And Product Specifications

Pharmaceutical and feed-grade L-methionine specifications typically include limits on oxidized impurities, including methionine sulfoxide 1,8. Analytical methods must be implemented to:

  • Quantify methionine sulfoxide content in final products using HPLC, mass spectrometry, or enzymatic assays 2,12
  • Monitor oxidation during storage, particularly for formulations exposed to air, light, or elevated temperatures 4
  • Validate the effectiveness of antioxidant additives or protective packaging in preventing methionine oxidation 4

Research on methionylmethionine oxidation products has demonstrated that sulfoxides exhibit increased water solubility compared to the parent compound, which may affect formulation properties and bioavailability 4. This finding has implications for both quality control specifications and potential applications of controlled oxidation in product development 4.

Applications Of Methionine Sulfoxide Chemistry

Pharmaceutical And Nutraceutical Development

Understanding methionine sulfoxide formation is critical for developing stable biopharmaceutical formulations, as oxidation of methionine residues in therapeutic proteins can lead to loss of activity, altered pharmacokinetics, or increased immunogenicity 2. Specific applications include:

  • Protein therapeutics stabilization: Formulation scientists must identify and protect susceptible methionine residues in monoclonal antibodies, enzymes, and peptide drugs from oxidation during manufacturing, storage, and administration 2
  • Oxidative stress biomarkers: Methionine sulfoxide levels in proteins serve as indicators of oxidative damage in neurodegenerative diseases, aging, and inflammatory conditions, enabling diagnostic test development 2
  • Antioxidant evaluation: The methionine/methionine sulfoxide system provides a model for assessing antioxidant efficacy in pharmaceutical and cosmetic formulations 4

The development of methionine sulfoxide-specific antibodies has enabled researchers to identify proteins showing increased methionine sulfoxide levels in disease states, facilitating biomarker discovery and validation 2. These tools are particularly valuable for studying oxidative stress-related diseases where protein oxidation plays a pathogenic role 2.

Cosmetic And Personal Care Applications

Oxidation products of methionylmethionine, including sulfoxides and sulfones, have found applications in cosmetic formulations for nail and hair treatment 4. Key advantages of these oxidized derivatives include:

  • Reduced odor: Sulfoxides and sulfones of methionylmethionine are odorless compared to the parent compound, improving consumer acceptability 4
  • Enhanced solubility: Increased water solubility facilitates incorporation into aqueous cosmetic formulations 4
  • Color stability: Oxidation products are colorless, avoiding discoloration issues in finished products 4

Cosmetic formulations containing sulfoxides and sulfones of D-methionyl-L-methionine, L-methionyl-D-methionine, and D-methionyl-D-methionine stereoisomers have been developed for topical application 4. The controllable solubility achieved through different oxidation stages allows formulators to optimize product texture and delivery characteristics 4.

Analytical And Research Tool Development

Methionine sulfoxide chemistry has enabled the development of novel analytical reagents and research tools 12. Fluorescently-labeled reducing agents bearing covalently-linked reporter tags provide sensitive methods for quantifying oxidation-reduction phenomena in proteins and peptides 12. These reagents offer advantages over traditional methods:

  • Improved safety: Elimination of toxic reagents like cyanogen bromide and radioactive compounds 12
  • Enhanced sensitivity: Fluorescence detection enables quantification at lower protein concentrations 12
  • Simplified workflows: Direct measurement of oxidized reducing reagent eliminates complex separation steps 12

Kits incorporating these novel reagents, methionine sulfoxide reductase enzymes, and standardized protocols enable researchers to analyze methionine sulfoxide content in protein samples and assess disulfide linkages in polypeptides 12. These tools support studies in protein chemistry, oxidative stress biology, and pharmaceutical development 12.

Structural Considerations: Methionine Sulfoxide Stereochemistry

The oxidation of methionine to methionine sulfoxide creates a chiral center at the sulfur atom, generating two diastereomeric forms (S- and R-sulfoxides) that exhibit distinct biological properties 2,4. This stereochemical complexity has important implications:

  • Enzyme specificity: Methionine sulfoxide reductase enzymes show stereospecific activity, with MsrA reducing the S-form and MsrB reducing the R-form 2
  • Protein structure effects: The two diastereomers may have different impacts on protein folding and stability when present at specific positions 2
  • Analytical challenges: Complete characterization of methionine oxidation in proteins requires methods capable of distinguishing between S- and R-sulfoxide forms 2,12

Studies on methionylmethionine stereoisomers (D-methionyl-L-methionine, L-methionyl-D-methionine, and D-methionyl-D-methionine) have revealed that oxidation can occur at either methionine residue, producing mono-sulfoxides, di-sulfoxides, and ultimately sulfones under strong oxidizing conditions 4. The specific oxidation pattern affects the physicochemical properties of the resulting compounds, including solubility, stability, and biological activity 4.

Relationship To L-Methionine Sulfoximine Chemistry

While distinct from methionine sulfoxide, L-methionine sulfoximine (MSO) represents another oxidized derivative of methionine with important biological activities 3,6,7. MSO is a potent inhibitor of glutamine synthetase and has been investigated for therapeutic applications in conditions involving glutamine metabolism dysregulation 3,6,7. Key differences between methionine sulfoxide and methionine sulfoximine include:

  • Chemical structure: Methionine sulfoxide contains a sulfoxide group (S=O), while methionine sulfoximine contains a sulfoximine group (S(=O)=NH) 3,6
  • Biological activity: Methionine sulfoxide primarily affects protein structure and function through oxidative modification, whereas MSO acts as an enzyme inhibitor 3,6,7
  • Reversibility: Methionine sulfoxide can be enzymatically reduced back to methionine by MSR, while MSO forms irreversible complexes with glutamine synthetase 6,7

Research on MSO has established that only the L-methionine-S-sulfoximine stereoisomer inhibits glutamine synthetase and causes convulsions in animal models, demonstrating the importance of stereochemistry in biological activity 6,7. Novel dosage forms of L-methionine S-sulfoximine (≤10 mg/kg body weight over one week, preferably ≤2.5 mg/kg) have been developed to minimize convulsant side effects while maintaining therapeutic efficacy for treating hyperammonemic encephalopathy 3,6,7.

Process Optimization Strategies For Minimizing Methionine Oxidation

Enzymatic Synthesis Conditions

Biotechnological L-methionine production processes can be optimized to minimize methionine sulfoxide formation through careful control of reaction conditions 1,5,8,9:

  • Oxygen exclusion: Conducting enzymatic reactions under anaerobic or microaerobic conditions reduces ROS generation and methionine oxidation 1,9
  • Reducing agent supplementation: Addition of DTT, β-mercaptoethanol, or other reducing agents maintains a reducing environment throughout the synthesis 1,5
  • pH optimization: Maintaining optimal pH ranges (typically 6.5-8.0 for O-acetylhomoserine sulfohydrylase reactions) minimizes oxidative side reactions 8
  • Temperature control: Lower reaction temperatures (25-37°C) reduce oxidation rates while maintaining acceptable enzymatic activity 8

The use of enzymes from specific bacterial sources can also influence oxidation susceptibility. For example, O-acetylhomoserine sulfohydrylase from Corynebacterium humireducens and mutants thereof have been employed in L-methionine synthesis, with enzyme selection affecting both conversion efficiency and product purity 8. Similarly, improved variants such as MetZ_Rsp_I3N_F65Y_V104A from Rhodobacter sphaeroides offer enhanced conversion rates and shortened reaction times, potentially reducing oxidative exposure 8.

Precursor And Intermediate Handling

Proper handling of L-methionine precursors and intermediates is essential for preventing oxidation 1,5,8,9:

  • **O-acetyl
OrgApplication ScenariosProduct/ProjectTechnical Outcomes
UNIVERSITY OF KANSASDiagnostic testing for oxidative protein damage in clinical specimens, biomarker discovery for neurodegenerative diseases, and screening oxidative stress-related pathologies.Methionine Sulfoxide Antibody KitAntibodies specifically recognize methionine sulfoxide residues in proteins, enabling identification of oxidatively damaged proteins in neurodegenerative diseases and oxidative stress conditions.
ARKEMA FRANCEIndustrial biotechnological production of pharmaceutical and feed-grade L-methionine with reduced oxidative impurities and improved product purity.Enzymatic L-Methionine Production SystemTwo-step enzymatic process converts dimethyl disulfide (DMDS) to methyl mercaptan then to L-methionine, minimizing oxidative side reactions and methionine sulfoxide formation through controlled reducing conditions.
EVONIK OPERATIONS GMBHCosmetic formulations for nail and hair treatment requiring improved solubility, reduced odor, and enhanced aesthetic properties.Methionylmethionine Sulfoxide DerivativesOxidized methionylmethionine products (sulfoxides and sulfones) exhibit increased water solubility, odorless properties, and colorless appearance compared to parent compound.
PROMEGA CORPORATIONProtein quality control in biopharmaceutical development, oxidative stress research, and analysis of disulfide linkages in peptides and proteins.Fluorescent Methionine Sulfoxide Detection KitFluorescently-labeled reducing agents with covalently-linked reporter tags enable quantification of methionine sulfoxide through methionine sulfoxide reductase enzymatic assay, eliminating toxic reagents like cyanogen bromide.
MSO PHARMA LLCTreatment of progressive hyperammonemic encephalopathy and cerebral edema in patients with glutamine metabolism disorders.L-Methionine S-Sulfoximine Low-Dose FormulationNovel dosage form (≤10 mg/kg body weight per week) inhibits glutamine synthetase without convulsant side effects, reducing brain swelling in hyperammonemic conditions.
Reference
  • Method for producing l-methionine
    PatentActiveSG11201802624YA
    View detail
  • Methionine sulfoxide antibodies
    PatentInactiveUS8409824B2
    View detail
  • A novel dosage form of l-methionine s-sulfoximine
    PatentInactiveCA2474813A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png